首页> 外国专利> PHARMACEUTICAL COMPOSITE FORMULATION COMPRISING NON-STEROIDAL ANTI-INFLAMMATORY DRUG AND PROTON PUMP INHIBITOR, AND METHOD FOR PREPARING THE SAME

PHARMACEUTICAL COMPOSITE FORMULATION COMPRISING NON-STEROIDAL ANTI-INFLAMMATORY DRUG AND PROTON PUMP INHIBITOR, AND METHOD FOR PREPARING THE SAME

机译:包含非甾体类抗炎药和质子泵抑制剂的药物复合制剂及其制备方法

摘要

PURPOSE: A pharmaceutical composite with a double-layer tablet containing basic additives is provided to suppress generation of related compounds, to improve stability, and to enhance bioavailability, thereby being used as a therapeutic agent for treating hypertension and hypercholesterolemia. CONSTITUTION: A pharmaceutical composite comprises: a first layer containing non-steroidal anti-inflammatory drug (NSAID) or a pharmaceutically acceptable salt thereof; and a second agent containing proton pump inhibitors (PPIs) or a pharmaceutically acceptable salt thereof and a basic additive. The NSAID is naproxen. A method for manufacturing the pharmaceutical composite comprises the steps of: preparing granules for the first layer, containing naproxen or a pharmaceutically acceptable salt thereof; preparing granules for the second layer, containing PPIs and the basic additives; and tableting the granules. [Reference numerals] (AA) Double layer composite; (BB) Second layer: proton pump inhibitor + alkaline addictive; (CC) First layer: NSAID
机译:目的:提供具有碱性添加剂的双层片剂的药物复合物,以抑制相关化合物的产生,提高稳定性,并提高生物利用度,从而用作治疗高血压和高胆固醇血症的治疗剂。组成:药物复合物包括:第一层含有非甾体类抗炎药(NSAID)或其药学上可接受的盐;含有质子泵抑制剂(PPI)或其药学上可接受的盐和碱性添加剂的第二试剂。 NSAID是萘普生。制造药物复合物的方法包括以下步骤:制备用于第一层的颗粒,该颗粒含有萘普生或其药学上可接受的盐;为第二层制备包含PPI和基本添加剂的颗粒;和压片颗粒。 [附图标记](AA)双层复合材料; (BB)第二层:质子泵抑制剂+碱性成瘾剂; (CC)第一层:NSAID

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号